|
|
Article: Eurogentec Announces Agreement to Acquire AnaSpec, Inc.
- Article from:
- Biotech Week
- Article date:
- November 18, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Eurogentec S.A. ("Eurogentec") announces a final agreement for the acquisition of AnaSpec Inc ("AnaSpec" or the "Company"), a privately held proteomics company based in Fremont, California. Founded in 1993, AnaSpec is a leading provider of integrated proteomics solutions for life science research and diagnostics with expertise in peptides synthesis, labeled peptides and antibodies, fluorescent dyes and enzyme activity assays. AnaSpec has developed one of the world's largest collections of catalog and dye-labeled peptides in the fields of Alzheimer Disease, Multiple Sclerosis and enzyme inhibitor screening. Leveraging its expertise in peptide, antibodies and fluorescent ...
Related newspaper, magazine, and journal articles:
|
|
Article: AnaSpec Celebrates 15 Year Anniversary.
Biotech Week;
October 8, 2008 ;
608 words
...AnaSpec has celebrated its 15th anniversary of ... worldwide. Since its inception in 1993, AnaSpec has provided drug discovery reagents to ... Starting with a staff of less than 10, AnaSpec now employs close to 100 employees and ...
|
|